Methamphetamine Use and the Impact on Child Welfare

Nancy K. Young, Ph.D., Director
National Center on Substance Abuse and Child Welfare
Jay Wurscher, Director
Oregon Child Welfare Addiction Services

Presented at CWLA Methamphetamine Teleconference
September 22, 2005

Overview, Treatment and Risks to Children

Overview, Treatment and Risks to Children

1. NCSACW
2. Scope of the Problem
3. Patterns of Use
4. Effects of Meth Addiction
5. Risks to Children
6. Treatment for Meth

NCSACW

A Program of the Substance Abuse and Mental Health Services Administration Center for Substance Abuse Treatment
and the Administration on Children, Youth and Families Children’s Bureau Office on Child Abuse and Neglect

NCSACW Mission

NCSACW Consortium

Recent Products

Scope of the Problem

Scope of the Problem

Meth/Amphetamine Treatment Admission Rate (Graphic)
Per 100,000 Population Aged 12 or Older - 1993-2003

Eastward Spread of Methamphetamine (Graphic)

Treatment Admissions by Primary Substance - 2003

Alcohol 42%
Heroin/Other Opiates 18%
Marijuana 15%
Cocaine 14%
Meth/Amphetamine and
Other Stimulants
7%

Impact of Increasing Methamphetamine Use

Smoked Methamphetamine/Amphetamine (Graphic)
Treatment Admissions, by Race/Ethnicity: 1992 and 2002

Source: 2002 SAMHSA Treatment Episode Data Set (TEDS).

Meth/Amphetamine & Cocaine Treatment Admissions
According to Census Division 2003
RATE per 100,000

Source: Treatment Episode Data Set (TEDS)

Gender Differences

Treatment Admissions: Percent Methamphetamine/Amphetamine as Primary Substance, By Gender

  Male Female
1995 2.9% 6.1%
1997 3.3% 6.8%
1999 3.3% 6.9%
2001 4.5% 8.8%
2003 6.0% 11.0%

Source: Treatment Episode Data Set (TEDS)

Methamphetamine/Amphetamine Admissions: Gender Breakdown, 2002

  Male Female
All Ages 55% 45%
12-14 year-olds 30% 70%
15-17 year-olds 43% 57%

Source: Treatment Episode Data Set (TEDS).

Female Treatment Admissions (Graphic)
States with Highest % of Meth/Amphetamine as Primary Substance

Trends in Primary Substance Use (Graphic)
Treatment Admissions for Pregnant Females by Primary Substance 1995-2003

Foster Care Population and Persons Who First Used Crack or Methamphetamine in Prior Year (Graphic)

Effects of Methamphetamine Addiction

Short-Term Effects of Methamphetamine (Graphic)

Methamphetamine Chronic Physical Effects

Methamphetamine Chronic Psychological Effects

Cognitive Effects

Risks to Children When Parents Use Meth

Six Different Situations for Children

Source: Nancy Young, Ph.D., Testimony before the U.S. House of Representatives Government Reform Subcommittee on Criminal Justice, Drug Policy, and Human Resources, July 26, 2005

Six Different Situations for Children

Source: Nancy Young, Ph.D., Testimony before the U.S. House of Representatives Government Reform Subcommittee on Criminal Justice, Drug Policy, and Human Resources, July 26, 2005

Parent Uses or Abuses Meth

Risks to safety and well-being of children:

Source: Nancy Young, Ph.D., Testimony before the U.S. House of Representatives Government Reform Subcommittee on Criminal Justice, Drug Policy, and Human Resources, July 26, 2005

Parent Is Dependent on Meth

Risks to safety and well-being of children:

Source: Nancy Young, Ph.D., Testimony before the U.S. House of Representatives Government Reform Subcommittee on Criminal Justice, Drug Policy, and Human Resources, July 26, 2005

Mother Uses Meth While Pregnant

Sources: Anglin et al. (2000); Oro & Dixon, (1987); Rawson & Anglin (1999); Dixon & Bejar (1989); Smith et al. (2003); Shah (2002)

Mother Uses Meth While Pregnant

Source: Nancy Young, Ph.D., Testimony before the U.S. House of Representatives Government Reform Subcommittee on Criminal Justice, Drug Policy, and Human Resources, July 26, 2005

Mother Uses While Pregnant

Sources: Vega; SAMHSA, OAS, National Survey of Alcohol and Drug Use During Pregnancy, 2002 and 2003

Mother Uses While Pregnant

Home environment is the critical factor in the child’s outcome

Consequences can be mediated

Shah, R. (2005, June). From NASADAD presentation

Parent “Cooks” Small Quantities of Meth

Source: Nancy Young, Ph.D., Testimony before the U.S. House of Representatives Government Reform Subcommittee on Criminal Justice, Drug Policy, and Human Resources, July 26, 2005

Environmental Methamphetamine Exposure and Risks

Source: Mason (2004)

Parent Involved in Trafficking

Source: Nancy Young, Ph.D., Testimony before the U.S. House of Representatives Government Reform Subcommittee on Criminal Justice, Drug Policy, and Human Resources, July 26, 2005

Parent Involved in Super Lab

Source: Nancy Young, Ph.D., Testimony before the U.S. House of Representatives Government Reform Subcommittee on Criminal Justice, Drug Policy, and Human Resources, July 26, 2005

Number of Children in Meth Labs

  2000 2001 2002 2003*
Number of incidents 8,971 13,270 15,353 14,260
Incidents with children present 1,803 2,191 2,077 1,442
Children residing in labs 216 976 2,023 1,447
Children affected** 1,803 2,191 3,167 3,419
Children exposed to toxic chemicals 345 788 1,373 1,291
Children taken into protective custody 353 778 1,026 724
Children injured 12 14 26 44
Children killed 3 0 2 3

*The 2003 figure for the number of incidents is calendar year, while the remaining data in the column are for fiscal year
**Data for 2000 and 2001 may not show all children affected

4 years = 2,881; all children ~1,000,000

Medical Interventions for Children

Source: Colorado DEC

Treatment for Methamphetamine

CSAT’s Methamphetamine Treatment Project

Matrix Model

Urinalysis Results

Results of UA tests at discharge, 6 months and 12 months post admission *

  Matrix Group TAU Group
D/C: 66% MA-free 65% MA-free
6 mo: 69% MA-free 67% MA-free
12 mo: 59% MA-free 55% MA-free

*Over 80% follow-up rate in both groups at all points

Similar Outcomes

Treatment Outcomes for Women (Graphic)

Gender Differences and Implications for Treatment

Behavior Symptom Inventory (BSI) (Graphic)
Scores at Baseline

Beck Depression Inventory (BDI) (Graphic)
Scores at Baseline

Self-Reported Reasons for Starting Methamphetamine Use (Graphic)

Gender Differences and Implications for Treatment

What Predicts Longer Abstinence?

Longer abstinence following treatment for women with:

M.L. Brecht, Ph.D., et al. (2005)

Sacramento, California Model of Effective Child Welfare and Substance Abuse Services

Treatment Discharge Status by Primary Drug Problem

  Unsatisfactory Satisfactory
Heroin 64.4 31.6
Alcohol 29.3 70.7
Meth 30.0 70.0
Cocaine 46.8 53.2
Marijuana 30.1 69.9

18-Month Child Placement Outcomes by Parent Primary Drug Problem (Graphic)

Methamphetamine: Implications for Workers

Methamphetamine: Implications for Workers

  1. Signs of Use and Warning Signs for Workers
  2. Oregon’s Response

Signs of Use and Warning Signs for Workers

Signs of Methamphetamine Use and Use of Other Stimulants

Source: Crowell & Webber (2001)

Warning Signs for Workers

Source: Crowell & Webber (2001)

Other Severe Signs of Meth Use

Source: Crowell & Webber (2001)

Natural Rewards Elevate Dopamine Levels (Graphic)

Effects of Drugs on Dopamine Levels (Graphic)

Denial = Super-memory Imprinting

Research on Cognitive Impairments of MA addicts

“Methamphetamine: Snapshot Phenomenon” Wurscher & Martin (Graphic)

Oregon’s Response

Oregon 2004

Oregon CW Success

Oregon Response

Summary

Summary

For Further Information

SAMHSA Resources

ATTC’s Introduction to Evidence-Based Treatments for Methamphetamine

Contact NCSACW

References

Anglin, M., Burke, C., Perrochet, B., Stamper, E. & Dawud-Noursi, S. (2000). History of the methamphetamine problem. Journal of Psychoactive Drugs, 32(2), 137-141.

Brecht, M.-L., M. D. Anglin, et al. (2005). "Coerced Treatment for Methamphetamine Abuse: Differential Patient Characteristics and Outcomes." The American Journal of Drug and Alcohol Abuse 31(2): 337.

Brecht, M.L.(2004) Women and Methamphetamine: Characteristics, Treatment Outcomes. Presentation to the Center
For Substance Abuse Treatment, State Systems Development Conference. August 13.

Cohen, Judith, Ph.D. Presentation to NASADAD, June 2005.

Colorado DEC. Retrieved from www.colodec.org/decpapers/Documents/DEC%20Medical%20Protocol.pdf

Crowell and Webber, 2004. Retrieved from www.drugfreeinfo.org/PDFs/strengthensupervision.pdf.

Dixon, S.D., & Bejar, R. (1989). Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: Incidence and clinical correlates. Journal of Pediatrics, 115(5 Pt 1), 770-778.

Ferguson, T. (2001). Overview of medical toxicology and potential exposures to clandestine drug laboratories in California. Paper presented to the Minnesota Department of Health.

Lundahl, L.H., Keenan, P., Schuster, C.R., & Johanson, C.E. (2004, June). Neurocognitive function in chronic high dose methamphetamine abusers following long term abstinence. Poster session presented at the 66th Annual Scientific Meeting of the College on Problems of Drug Dependence, San Juan, Puerto Rico.

Mason, A. P. 2004. Methamphetamine labs. Presented at the annual conference of the North Carolina Family-Based, Services Association.

Obert, J.L., London, E.D., & Rawson, R.A. (2002). Incorporating brain research findings into standard treatment: An example using the Matrix Model. Journal of Substance Abuse Treatment, 23(2), 107-113.

Office of Applied Studies, Substance Abuse and Mental Health Services Administration, Treatment Episode Data Set (TEDS).
Office of Applied Studies, Substance Abuse and Mental Health Services Administration, National Survey of Alcohol and Drug Use During Pregnancy, 2002 and 2003.

Oro, A.S., & Dixon, S.D. (1987). Perinatal cocaine and methamphetamine exposure: Maternal and neonatal correlates. Journal of Pediatrics, 571-578.

Rawson, Richard, Ph.D., Presentation to SAMHSA, August 2005.

Rawson, R., & Anglin, M.D. (1999, June). Methamphetamine: New knowledge, new treatments. Retrieved April 2004, from the UCLA Integrated Substance Abuse Programs Web site: http://www.uclaisap.org/slides/Index46/index.htm

Simon, S. (1999). Cognitive impairment in individuals currently using methamphetamine. Retrieved April 2004, from the UCLA Integrated Substance Abuse Programs Web site: http://www.uclaisap.org/slides/Index46/sld034.htm

Smith, L., Yonekura, M.L., Wallace, T., Berman, N., Kuo, J., & Berkowitz, C. (2003). Effects of prenatal methamphetamine exposure on fetal growth and drug withdrawal symptoms in infants born at term. Journal of Developmental and Behavioral Pediatrics, 24(1):17-23.

Shah, R. (2005, June). From NASADAD presentation

Thompson, P.M., Hayashi, K.M., Simon, S.L., Geaga, J.A., Hong, M.S., Sui, Y., et al. (2004). Structural abnormalities in the brains of human subjects who use methamphetamine. Journal of Neuroscience, 24(26), 6028-6036.

Vaughn, C. (2003). Get up to speed on methamphetamine use. NCADI Reporter. Retrieved from http://www.health.org/newsroom/rep/215.aspx

Vega et al (1993), Profile of Alcohol and Drug Use During Pregnancy in California, 1992.

Volkow, N.D., Chang, L, Wang, G.J., Fowler, J.S., Leonido-Yee, M., Franceschi, D., et al. (2001b). Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. American Journal of Psychiatry, 158, 377-382.

Young, Nancy K., Ph.D. Testimony before the U.S. House of Representatives Government Reform Subcommittee on Criminal Justice, Drug Policy, and Human Resources, July 26, 2005.

Zickler, P. (2000). Brain imaging studies show long-term damage from methamphetamine abuse. NIDA Notes, 15(3).